Corteva, Inc. Earnings Recaps
Q2 2026
Aug 3, 2026
Corteva’s shares fell 11.9% post-earnings as the cautious outlook and signs of margin pressure outweighed solid first-half execution, disappointing investors despite raised full-year guidance.
Key takeaways
- First half net sales rose 4%, operating EBITDA increased 10%, and operating EPS grew 14%, reflecting steady execution across seed and crop protection.
- Pricing in crop protection was essentially flat amid competitive market conditions, indicating limited pricing power and potential margin headwinds.
- Management highlighted ongoing pricing pressure in certain crop protection segments and farmer caution on discretionary spending, signaling deceleration risks.
- Raised full-year guidance to $4.1-$4.3 billion EBITDA and $3.60-$3.80 EPS, factoring in productivity gains and licensing growth, but tempered by a “healthy respect” for market risks.
- Separation from Dow Inc. remains on schedule and on budget, with progress on leadership and organizational milestones offsetting separation-related expenses.
Q1 2026
May 8, 2026
Corteva shares dropped 5.8% after earnings as cautious farmer outlook and concerns about volume sustainability overshadowed solid Q1 margin expansion and reaffirmed guidance.
Key takeaways
- Q1 EBITDA rose 21% year-over-year with over 200 basis points of margin expansion, driven by price mix, volume gains, cost control, and currency benefits.
- Seed segment showed strong North American volume, partly due to timing shifts, supported by price mix gains globally despite tight farmer margins.
- Crop Protection volume grew with double-digit gains in new products and Spinosyns, reflecting demand for premium technologies.
- Full-year guidance was reaffirmed but included risks, notably a projected 3%-4% reduction in U.S. corn acreage as farmers shift to soybeans.
- Management acknowledged cautious and value-driven farmer sentiment, with increasing strategic crop mix decisions and geopolitical and input cost uncertainties potentially weighing on second-half performance.
Q3 2025
Nov 5, 2025
Corteva Agriscience reported strong third-quarter results characterized by double-digit EBITDA growth, driven by robust performance in both its Seed and Crop Protection segments, alongside a proactive strategy to separate into two public companies.
Key takeaways
- Third-quarter operating EBITDA rose by 14% year-over-year, with the company raising its full-year EBITDA guidance to a range of $3.8 billion to $3.9 billion.
- The Seed business achieved $200 million in productivity benefits and is on track to achieve double-digit trade penetration for Conkesta in Brazil.
- The Crop Protection segment anticipates high single-digit EBITDA growth for the year, supported by demand for differentiated technologies and the launch of the new insecticide Varpelgo.
- Corteva expects to deliver over $600 million in controllable benefits for 2025, up from a prior estimate of $530 million.
- The planned separation into two public companies is expected to enhance growth potential for the Seed and Crop Protection units, with a target completion set for the second half of 2026.